December 13, 2007 - TomoTherapy Inc. announced that the University Hospital of Lausanne (CHUV) has begun treating patients with the TomoTherapy Hi-Art treatment system, the first to be installed in Switzerland.

The system is an advanced radiation therapy system for the treatment of a wide variety of cancers, combining integrated CT imaging with conformal radiation therapy to deliver radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company completed its initial public offering in May 2007.

CHUV is one of the 5 major university hospitals in Switzerland, providing primary to tertiary care in all domains of medicine, focusing primarily on cancer. Many doctors and scientists are involved in basic, translational and clinical research in cancer medicine, which contributes to its international visibility. A number of clinicians are currently involved in national and international cooperative cancer research groups, including SAKK, EORTC and hold officer’s positions or have a leading role as principal investigators of international trials. The department of Radiation Oncology has an active role and has contributed to a number of major international studies in various fields of oncology and has a leading position in Switzerland.

For more information: www.tomotherapy.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now